LDR’s IPO Bid, FDA Approvals Give Spine Much Needed Adjustment
This article was originally published in The Gray Sheet
Executive Summary
The spine device firm LDR filed to raise up to $69 million in an initial public offering just as it gained FDA approval for its Mobi-C cervical disc for one- and two-level indications. Device investors will keep a close watch on the IPO, which has not been staged by a venture-backed spine startup since 2007.